Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery

Oct.12.2024
Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
A new Innokin Trine e-cigarette with replaceable battery has hit shelves in Europe, meeting upcoming EU regulations.

Recently, 2Firsts noticed a new type of replaceable battery e-cigarette called the Innokin Trine being showcased at a tobacco exhibition in Dortmund. The product, launched by e-cigarette brand Innokin, is now available on e-cigarette retail websites in regions such as the UK and Germany. With its design allowing for replaceable batteries, the product complies with the new regulations set to be implemented by the EU Battery Directive in 2026.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Innokin Trine displayed at the tobacco exhibition in Dortmund by Innokin|Image source: 2Firsts


At the recent Dortmund tobacco exhibition, several exhibitors showcased e-cigarette products with replaceable batteries, including disposable, pod-based, and open-system devices, in response to the EU's Battery Directive. According to the directive, by 2026, batteries in portable devices (such as disposable e-cigarettes) must be easily removable and replaceable by the user.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image Source | Innokin Official Website


The newly released Innokin Trine, an open system product from Innokin, complies with the upcoming new regulations in the European Union market.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin official website


In addition, the main feature of Trine is its "three-in-one" structure: atomizer, detachable and rechargeable battery, control panel. At the same time, the detachable and rechargeable battery enhances the convenience and durability of the device.

Innokin Trine: A Revolutionary Rechargeable E-Cigarette with Replaceable Battery
Image source | Innokin brand official website


Specifically, the main product features of the Innokin Trine include:


E-liquid capacity: 2ml Nicotine concentration: Supports a variety of nicotine levels in e-liquid Battery capacity: 1000mAh removable battery Charging method: Supports Type-C fast charging.


Trine Power Hub charger charges


Backup batteries can also be purchased separately.


Power Mode: Provides a power output of 6-25W.


Function: - Suction activation


Support mouth to lung (MTL) or limit direct lung (RDL) inhale mode.


Compatible with a variety of e-liquid flavors.


Charging indicator light


The screen displays operational parameters such as output power and battery level.


Currently, the Innokin Trine has been listed on the official website of the Innokin e-cigarette brand and major distributor websites in Europe, with a selling price of approximately 19.95 euros.


In addition to the Innokin brand, other brands such as GOLISI and NEXIONE have also introduced similar products with replaceable batteries. 2Firsts will continue to monitor the latest products and market trends in replaceable battery e-cigarette products, providing the public with accurate and authoritative industry information.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland Vape Bill Passes Dáil, Setting Limits on Flavours, Packaging and Retail Display
Ireland’s Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026 has passed final stage in the Dáil and will move to the Seanad, with measures to limit vape flavours to tobacco or unflavoured products and tighten rules on packaging colours, retail advertising, in-store displays and sales of nicotine pouches to minors.
News
Jun.26 by 2Firsts Perspectives
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
Trump’s Tobacco Investments and Industry Donations Draw Scrutiny as FDA Eases Vape and Nicotine Pouch Rules
A report by KFF Health News says that as the Trump administration pursued a series of policies favorable to the nicotine and tobacco industry, President Donald Trump increased his holdings in tobacco companies while benefiting from substantial industry-linked political donations, prompting questions from public health advocates about potential conflicts of interest and regulatory direction.
Jun.12
Pennsylvania Updates ENDS Certification List as Chinese-Linked Manufacturers Enter State Review
Pennsylvania Updates ENDS Certification List as Chinese-Linked Manufacturers Enter State Review
Pennsylvania’s June 26 Pending ENDS Certifications list includes 23 manufacturers under review, including Shenzhen Smoore, Shenzhen IVPS, YME Technology and China-linked Boulder International. The list shows state-level vape regulation moving beyond retail brands toward manufacturer-based market access alongside FDA oversight.
Regulations
Jul.06 by 2Firsts Perspectives
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
South Korea Rejects 16 Trillion Won Tax-Evasion Claim Over Chinese Synthetic Nicotine
The South Korean government rejected allegations that Chinese synthetic-nicotine e-liquids were linked to about 16 trillion won in tobacco tax evasion, saying China does not ban synthetic nicotine exports and the estimate is difficult to verify, while acknowledging that pre-law synthetic-nicotine inventory is effectively difficult to tax.
Market
Jun.25
Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Hawaii Attorney General Anne Lopez is co-leading a coalition of 19 states and jurisdictions urging the Fédération Internationale de l’Automobile (FIA) and Formula 1 to end sponsorships involving tobacco and nicotine products, including nicotine pouch brands such as Zyn and Velo.
News
Jun.09
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Ispire and Jincheng Pharma Form Joint Venture to Enter Global High-Growth Nicotine Pouch Market
Summary Ispire Technology announced a strategic joint venture with Chinese pharmaceutical company Jincheng Pharma to manufacture and commercialize nicotine pouch products. The partnership combines pharmaceutical-grade production capabilities with Ispire’s global regulatory infrastructure and distribution network as the company expands beyond vaping hardware into oral nicotine products.
Business
May.13